Catalyst

Slingshot members are tracking this event:

Blueprint Medicines' (BPMC) to Present Avapritinib in Advanced Systemic mastocytosis (SM) Phase 2 Data at AACR April 11, 2021 from 2pm ET

Source Link:
https://www.prnewswire.com/news-releases/blueprint-medicines-reports-fourth-quarter-and-full-year-2020-financial-results-301229642.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
BPMC Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Apr 11, 2021
Occurred Source:
https://ir.blueprintmedicines.com/news-releases/news-release-details/blueprint-medicines-data-highlight-clinical-leadership-systemic
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Advanced Systemic Mastocytosis, Avapritinib, Aacr
About Us
Media Center
Connect with Us
© 2025 Slingshot Insights. All rights reserved.